The first phase of chronic hepatitis B, the immune tolerance phase, is traditionally considered to be a quiescent stage of disease. Emerging data now suggests the contrary, with immunological, pathological and virological evidence supporting an underlying active disease, signifying the need to consider earlier treatment commencement.
- Wai-Kay Seto
- Man-Fung Yuen
